tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Ushigome H et al. Two cases of tacrolimus-induced alopecia following kidney transplantation. 1999 Transplant. Proc. pmid:10578326
Bush WW Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. 1999 AACN Clin Issues pmid:10578712
Lowry PW et al. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. 1999 Inflamm. Bowel Dis. pmid:10579116
Mathieu P et al. Conversion of cyclosporine A to tacrolimus following heart transplantation. 1999 Can J Cardiol pmid:10579737
Horigome A et al. Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients. 1999 Br J Clin Pharmacol pmid:10583028
Busque S et al. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. 1999 Ann Chir pmid:10584376
Wong TY et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. 1999 Am. J. Kidney Dis. pmid:10585325
Le Bricon T et al. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. 1999 Clin. Chem. pmid:10585359
Miyamoto S and Safer B Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation. 1999 Biochem. J. pmid:10585867
Tsuchida M et al. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+. 1999 J. Immunol. pmid:10586059
Agarwala S et al. Co-administration of co-trimoxazole does not augment tacrolimus-induced impairment in kidney function in rats. 1999 Ren Fail pmid:10586426
von Baum H et al. Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. 1999 Clin. Infect. Dis. pmid:10589909
Maes BD et al. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. 1999 Transplantation pmid:10589943
Fernandez LA et al. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. 1999 Transplantation pmid:10589951
Batten P et al. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. 1999 Transplantation pmid:10589954
Dickenmann MJ et al. Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. 1999 Transplantation pmid:10589963
Yamashita N et al. Nuclear factor kappa B mediates interleukin-8 production in eosinophils. 1999 Int. Arch. Allergy Immunol. pmid:10592469
Shimoyama M et al. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. 1999 Circulation pmid:10595959
Camacho R et al. Hypothemycin inhibits the proliferative response and modulates the production of cytokines during T cell activation. 1999 Immunopharmacology pmid:10598882
Briggs CJ et al. Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. 1999 Arch. Virol. pmid:10603169
Xu L et al. Potential for pharmacology of ryanodine receptor/calcium release channels. 1998 Ann. N. Y. Acad. Sci. pmid:10603942
Bers DM et al. Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. 1998 Ann. N. Y. Acad. Sci. pmid:10603944
MacFarlane GD et al. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function. 1999 Ther Drug Monit pmid:10604816
Wright DC et al. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents. 1999 Transpl. Immunol. pmid:10608297
Qi Z et al. Malononitrilamides and tacrolimus additively prevent acute rejection in rat cardiac allografts. 1999 Transpl. Immunol. pmid:10608300
Olyaei AJ et al. Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. 1999 Drug Saf pmid:10612271
Freudenberger R et al. Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. 1999 J. Heart Lung Transplant. pmid:10612383
Yen MT et al. Oscillopsia and pseudonystagmus in kidney transplant patients. 1999 Am. J. Ophthalmol. pmid:10612521
Bitker MO et al. [Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations]. 1999 Chirurgie pmid:10615774
Crétolle-Vastel C et al. [Role of calcineurin-dependent drugs on the immunosuppressive effect induced by the anti-LFA-1 antibody in a fetal intestinal transplantation model in mice]. 1999 Chirurgie pmid:10615777
van Hooff JP and Christiaans MH Use of tacrolimus in renal transplantation. 1999 Transplant. Proc. pmid:10616483
Charco R et al. CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens. 1999 Transplant. Proc. pmid:10616508
Kindt MV et al. Tacrolimus toxicity in rhesus monkey: model for clinical side effects. 1999 Transplant. Proc. pmid:10616519
Gaston RS Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens. 1999 Transplant. Proc. pmid:10616556
Land W Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation. 1999 Transplant. Proc. pmid:10616558
Hida H et al. Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats. 1999 Neurosci. Res. pmid:10616914
Hashii M et al. cADP-ribose potentiates cytosolic Ca2+ elevation and Ca2+ entry via L-type voltage-activated Ca2+ channels in NG108-15 neuronal cells. 2000 Biochem. J. pmid:10620496
Uchino T et al. Effect of FK 506 and lipo prostaglandin E1 on heart allograft survival in rats. 1999 Scand. Cardiovasc. J. pmid:10622549
Patella V et al. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. 2000 J. Immunol. pmid:10623799
Mehta P et al. Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation. 1999 Bone Marrow Transplant. pmid:10627642
Shapiro R et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. 1999 Transplantation pmid:10628763
Haines DD et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. 2000 J. Cardiovasc. Pharmacol. pmid:10630731
Paul LC Dialysis and transplantation. 1999 Curr. Opin. Nephrol. Hypertens. pmid:10630810
Vanrenterghem YF Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine? 1999 Curr. Opin. Nephrol. Hypertens. pmid:10630811
Wang-Fan W et al. Application of centrifugal counter-current chromatography to the separation of macrolide antibiotic analogues. I. Selection of solvent systems based on solubility and partition coefficient investigations. 1999 J Chromatogr A pmid:10630872
Furutani M et al. FK506 binding protein from a thermophilic archaeon, Methanococcus thermolithotrophicus, has chaperone-like activity in vitro. 2000 Biochemistry pmid:10631007
Thiers BH Topical tacrolimus: treatment failure in a patient with alopecia areata. 2000 Arch Dermatol pmid:10632221
Lipper GM et al. Recent therapeutic advances in dermatology. 2000 JAMA pmid:10634322
Richter-Hintz D et al. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. 2000 J. Am. Acad. Dermatol. pmid:10642695
Bekersky I et al. Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg. 1999 Clin Ther pmid:10645753
Fuseler JW et al. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis. 2000 J. Rheumatol. pmid:10648038
Schrama YC et al. Concealed by veils. 2000 Nephrol. Dial. Transplant. pmid:10648679
Reddy KS et al. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. 2000 Transplantation pmid:10653379
Jain A et al. Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. 2000 Transplantation pmid:10653398
Wu GS et al. Deoxyspergualin delays xenograft rejection in the guinea pig-to-C6-deficient rat heart transplantation model. 1999 Transpl. Int. pmid:10654352
Novelli M et al. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. 1999 Transpl. Int. pmid:10654359
Tamura J et al. [The role of protein kinases and phosphatases in erythroid colony formation of elderly]. 1999 Nihon Ronen Igakkai Zasshi pmid:10655734
Tamura A et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. 2000 Surgery pmid:10660758
Schuppe H et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. 2000 Rheumatology (Oxford) pmid:10662882
McAlister VC et al. Sirolimus-tacrolimus combination immunosuppression. 2000 Lancet pmid:10665560
Chenhsu RY et al. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. 2000 Ann Pharmacother pmid:10669182
Tyagi MG and Thomas M Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression. 1999 Methods Find Exp Clin Pharmacol pmid:10669908
Winter C et al. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. 2000 Neuroscience pmid:10670442
Furukawa H et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. 2000 Transplantation pmid:10670633
Jordan ML et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. 2000 Transplantation pmid:10670637
Hirose R et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. 2000 Transplantation pmid:10670644
Sayo Y et al. Transforming growth factor beta induction of insulin gene expression is mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. 2000 Eur. J. Biochem. pmid:10672004
Misawa A et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:10673708
de Mattos AM et al. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. 2000 Am. J. Kidney Dis. pmid:10676738
Tisdale JF et al. Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. 2000 Semin. Hematol. pmid:10676915
Skuk D and Tremblay JP Progress in myoblast transplantation: a potential treatment of dystrophies. 2000 Feb 1-15 Microsc. Res. Tech. pmid:10679968
Del Poeta M et al. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. 2000 Antimicrob. Agents Chemother. pmid:10681348
Filler G et al. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. 2000 Pediatr. Nephrol. pmid:10684356
Sengoku T et al. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. 2000 Int. J. Immunopharmacol. pmid:10685002
Li XC and Strom TB Blocking T-cell costimulation in transplantation: opportunities and challenges. 2000 Transfusion pmid:10685997
Oppenheimer F Steroid withdrawal in renal transplant recipients. 2000 Transplant. Proc. pmid:10686314
Glynne R et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. 2000 Nature pmid:10688206
Suga Y et al. A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. 2000 J. Am. Acad. Dermatol. pmid:10688732
LaPres JJ et al. ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. 2000 J. Biol. Chem. pmid:10692406
Davis DL et al. Minor immunophilin binding of tacrolimus and sirolimus metabolites. 2000 Clin. Biochem. pmid:10693980
Bader A et al. Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions. 2000 Br. J. Pharmacol. pmid:10694240
Aronowski J et al. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. 2000 J. Cereb. Blood Flow Metab. pmid:10698072
White SA et al. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. 2000 Transplant. Proc. pmid:10700949
Braun F et al. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression. 2000 Transplant. Proc. pmid:10700989
White SA et al. Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors. 2000 Transplant. Proc. pmid:10701018
Williams ST et al. Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors. 2000 Transplant. Proc. pmid:10701022
Migita K et al. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. 2000 Lab. Invest. pmid:10701683
Rovira P et al. The impact of immunosuppressive drugs on the analysis of T cell activation. 2000 Curr. Med. Chem. pmid:10702633
Dumont FJ FK506, an immunosuppressant targeting calcineurin function. 2000 Curr. Med. Chem. pmid:10702636
Soran A et al. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. 1999 J Transpl Coord pmid:10703390
Ulsh PJ et al. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation. 1999 J Transpl Coord pmid:10703393
Bartucci MR Issues in cyclosporine drug substitution: implications for patient management. 1999 J Transpl Coord pmid:10703396
James JA et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. 2000 J. Clin. Periodontol. pmid:10703661
Lapa e Silva JR et al. Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus. 1999 Mediators Inflamm. pmid:10704085
Singh N et al. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. 2000 Transplantation pmid:10708096
Kuriyama S et al. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver. 2000 Int. J. Cancer pmid:10709105
Kitabayashi H et al. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. 2000 J. Cardiovasc. Pharmacol. pmid:10710126
DuBell WH et al. K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10710358
Egner R et al. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. 2000 Mol. Microbiol. pmid:10712705
Mamane Y et al. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. 2000 Immunity pmid:10714679